Kiniksa Pharmaceuticals, Ltd. (KNSA) Earnings
|
Expand Research on KNSA
| Next EPS Date | 10/28/26 *Est. | EPS Growth Rate | +30.4% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -1.3% | Revenue Growth Rate | +55.4% *Last Qtr. |
| Average % Move 1-Wk after EPS | +18.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/28/26 | Q226 | $0.30 | $0.31 | -$0.01 | $243.6M | $226.56M | = |  | | Details | |
| 4/28/26 | Q126 | $0.27 | $0.21 | +$0.06 | $214.27M | $207.12M | = | | | Details | |
| 2/24/26 | Q425 | $0.17 | $0.35 | -$0.18 | $202.13M | $199.61M | = | | | Details | |
10/28/25  |
Q325 | N/A | $0.32 | N/A | N/A | $166.67M | = | N/A | N/A | ||
| 7/29/25 | Q225 | $0.23 | $0.19 | +$0.04 | $156.79M | $145.28M | = | | | Details | |
| 4/29/25 | Q125 | $0.11 | $0.02 | +$0.09 | $137.7M | $131.07M | = | | | Details | |
| 2/25/25 |
Q424 | N/A | $0.03 | N/A | N/A | $123.42M | = | N/A | N/A | ||
| 10/29/24 | Q324 | -$0.18 | $0.01 | -$0.19 | $112.21M | $110.29M | = | | | Details |
